The role of mineralocorticoid receptors in hypothalamic-pituitary- adrenal axis regulation in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3339-3345

  Young, Elizabeth A ^a   Lopez, Juan F ^a   Murphy Weinberg, Virginia ^a   Watson, Stanley J ^a   Akil, Huda ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; PLACEBO; SPIRONOLACTONE;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOTROPIN RELEASE; FEMALE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ADULT; BETA-ENDORPHIN; CIRCADIAN RHYTHM; FEMALE; HOMEOSTASIS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PLACEBOS; RECEPTORS, MINERALOCORTICOID; SPIRONOLACTONE;

EID: 0031769481     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.9.3339     Document Type: Article

References (20)

1. deKloet R, Wallach G, McEwen BS. 1975 Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology. 96:598-605.
2. Reul JMH, de Kloet ER. 1985 Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 117:2505-2511.
3. Spencer RL, Young EA, Choo PH, McEwen BS. 1990 Glucocorticoid type I and type II receptor binding: estimates of in vivo receptor number, occupancy and activation with varying levels of steroid. Brain Res. 514:37-48.
4. Spencer RL, Miller AH, Moday H, Stein M, McEwen BS. 1993 Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues. Endocrinology. 133:1941-1950.
5. McEwen BS, Weiss JM, Schwartz LS. 1968 Selective retention of corticosterone by limbic structures in the rat brain. Nature. 220:911-913.
6. Dallman MF, Levin N, Cascio CS, Akana SF, Jacobsen L, Kuhn RW. 1989 Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteriods is mediated via type I corticosterone-preferring receptors. Endocrinology. 124:2844-2850.
7. Reul JMH, van den Bosch FR, de Kloet ER. 1987 Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol. 115:459-467.
8. Ratka A, Sutanto W, Bloemers M, de Kloet ER. 1989 On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology. 50:117-123.
9. Bradbury MJ, Akana SF, Dallman MF. 1994 Roles of type I and II corticosteriod receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Endocrinology. 134:1286-1296.
10. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. 1997 Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of CRH secretion. Biol Psychiatry. 41:1149-1155.
11. Young EA, Haskett RF, Grunhaus L, et al. 1994 Increased circadian activation of the hypothalamic pituitary adrenal axis in depressed patients in the evening. Arch Gen Psychiatry. 51:701-707.
12. Cahill CA, Matthews JD, Akil H. 1983 Human plasma β-endorphin-like peptides: a rapid high recovery extraction technique and validation of radioimmunoassay. J Clin Endocrinol Metab. 56:992-997.
13. Dodt C, Kern W, Fehm HL, Born J. 1993 Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology. 58:570-574.
14. Born J, Steinbach D, Dodt C, Fehm HL. 1997 Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep. J Clin Endocrinol Metab. 82:1106-1110.
15. Michelson D, Chrosous GP, Gold PW. 1994 Type I glucocorticoid receptor blockade does not affect baseline or ovine corticotropin-releasing-hormone-stimulated adrenocorticotropin hormone and cortisol secretion. Neuroimmunomodulation. 1:274-277.
16. Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett N. 1987 Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry. 44:328-336.
17. Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukush DK, Gallagher TF. 1973 Disrupted 24 hour patterns of cortisol secretion in psychotic depressives. Arch Gen Psychiatry. 28:19-24.
18. Halbreich U, Asnis GM, Schindledecker R, Zurnoff B, Nathan RS. 1985 Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry. 42:909-914.
19. Pfohl B, Sherman B, Schlecter J, Stone R. 1985 Pituitary/adrenal axis rhythm disturbances in psychiatric patients. Arch Gen Psychiatry. 42:897-903.
20. Linkowski P, Mendelwicz J, LeClercq R, et al. 1985 The 24 hour profile of ACTH and cortisol in major depressive illness. J Clin Endocrinol Metab. 61: 429-438.